Term Name: SGC-CLK-1
Synonyms: 4-(6-methoxypyrazolo[1,5-b]pyridazin-3-yl)-N-[3-methoxy-5-(trifluoromethyl)phenyl]pyrimidin-2-amine
Definition: A pyrazolopyridazine that is pyrazolo[1,5-b]pyridazine which is substituted by a 2-[3-methoxy-5-(trifluoromethyl)anilino]pyrimidin-4-yl group at position 3 and by a methoxy group at position 6. It is a human GSK-3beta, CDK2, CDK4, CLK1, CLK2, and CLK4 kinase inhibitor.
Ontology: ChEBI [CHEBI:156443]  ( EBI )

Relationships
is a type of: (trifluoromethyl)benzenes aromatic ether monomethoxybenzene pyrazolopyridazine pyrimidines secondary amino compound substituted aniline
has_role: EC 2.7.11.22 (cyclin-dependent kinase) inhibitor EC 2.7.11.26 (tau-protein kinase) inhibitor EC 2.7.12.* [dual-specificity kinases (those acting on Ser/Thr and Tyr residues)] inhibitor